← Back to Search

Intermittent Hypoxia for Balance Control

N/A
Waitlist Available
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre (20 minutes before) and post (20 minutes after) intermittent hypoxia or sham session
Awards & highlights

Study Summary

This trialwill study the effects of hypoxia on ankle muscle activation during walking & balance in younger & older adults. Participants will switch between hypoxia & sham, and muscle activation levels will be measured. It is hypothesized that hypoxia will increase muscle activation in both groups.

Eligible Conditions
  • Intermittent Hypoxia
  • Normoxia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre (20 minutes before) and post (20 minutes after) intermittent hypoxia or sham session
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre (20 minutes before) and post (20 minutes after) intermittent hypoxia or sham session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ankle
Soleus muscle structure

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intermittent HypoxiaExperimental Treatment1 Intervention
Participants will receive intermittent hypoxia and perform balance and gait assessments before and after the intermittent hypoxia session.
Group II: Normoxia (sham)Placebo Group1 Intervention
Participants will receive normoxia and perform balance and gait assessments before and after the normoxia session.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intermittent Hypoxia
2017
N/A
~50

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
353 Previous Clinical Trials
81,241 Total Patients Enrolled
2 Trials studying Intermittent Hypoxia
95 Patients Enrolled for Intermittent Hypoxia

Media Library

Intermittent Hypoxia Clinical Trial Eligibility Overview. Trial Name: NCT05463042 — N/A
Intermittent Hypoxia Research Study Groups: Intermittent Hypoxia, Normoxia (sham)
Intermittent Hypoxia Clinical Trial 2023: Intermittent Hypoxia Highlights & Side Effects. Trial Name: NCT05463042 — N/A
Intermittent Hypoxia 2023 Treatment Timeline for Medical Study. Trial Name: NCT05463042 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research program accept participants below the age of 35?

"According to the guidelines of this clinical trial, candidates must be aged 18 or older and no more than 80 years old."

Answered by AI

Who is eligible to enroll in this research endeavor?

"Prospective participants ought to have been diagnosed with hypoxia and be within the age range of 18-80. This medical trial is recruiting approximately 30 people."

Answered by AI

How many participants are currently involved in this clinical experiment?

"Affirmative. According to clinicaltrials.gov, enrollment for this research is ongoing with an initial posting date of September 1st 2022 and a latest update on October 31st 2022. 30 individuals are required from one medical centre."

Answered by AI

Are there any remaining slots open for participants in this clinical trial?

"Affirmative. The clinicaltrials.gov portal reveals that this investigation is currently recruiting patients, with the trial having first been posted on September 1st 2022 and most recently updated on October 31st 2022. This study requires 30 participants at a single location to be enrolled."

Answered by AI
~1 spots leftby Apr 2025